- 1. SB AS-2
- [A proprietary vaccine adjuvant consisting of an oil-in-water emulsion of saponin QS21 and monophosphoryl lipid A with potential immunostimulating activity. Mono-phosphoryl lipid A is a detoxified derivative of lipid A, a component of lipopolysaccharide (LPS) found in most gram-negative bacteria. QS21 is a purified saponin fraction extracted from the South American tree Quillaja saponaria Molina. When co-administered with peptide vaccines, the adjuvant vaccine may elicit strong humoral and cellular immune responses. ( NCI )] (UMLS (NCI) C0879269) SBAS-2 =Lipid; Pharmacologic Substance ;
| - 6. SBAC LYM LEUK W/O RMSION
- (UMLS (ICD9CM) C0153879) =Neoplastic Process
|
- 2. SB-AS02B Adjuvant
- [A proprietary oil-in-water emulsion specifically designed for combining protein preparations used in vaccines. SB-AS02B adjuvant contains monophosphoryl lipid A and QS21, a saponin extracted from the South American tree Quillaja Saponaria Molina. This agent may be used for formulating cancer-specific vaccine preparations such as those containing MAGE-3 melanoma protein. (NCI04) ( NCI )] (UMLS (NCI) C1327744) =Organic Chemical; Pharmacologic Substance
| - 7. SBAC MONO LEUK W RMSION
- (UMLS (ICD9CM) C0153902) =Neoplastic Process
|
- 3. SBAC LEUK UNS CL W RMSON
- (UMLS (ICD9CM) C0686591) =Neoplastic Process
| - 8. SBAC MONO LEUK W/O RMSON
- (UMLS (ICD9CM) C0153901) =Neoplastic Process
|
- 4. SBAC LEUK UNS CL W/O RMS
- (UMLS (ICD9CM) C0686590) =Neoplastic Process
| - 9. SBAC MYL LEUK W RMSION
- (UMLS (ICD9CM) C0153890) =Neoplastic Process
|
- 5. SBAC LYM LEUK W RMSION
- (UMLS (ICD9CM) C0153880) =Neoplastic Process
| - 10. SBAC MYL LEUK W/O RMSION
- (UMLS (ICD9CM) C0153889) =Neoplastic Process
|
home
